Highest development stage: Phase 1

Development status: Inactive

Gram-negative activity

Mechanism of Action/Target pathogen: Protein synthesis inhibitor. Potent activity against Gram positives including MRSA, Enterococci strains, H. influenzaeand M. catarrhalis with MIC90 ranging from 0.06- 4 µg/ml)